Functional Interactions among Yeast Rad51 Recombinase, Rad52
Mediator, and Replication Protein A in DNA Strand Exchange*
BinWei
Song and
Patrick
Sung
From the Department of Molecular Medicine/Institute of
Biotechnology, University of Texas Health Science Center,
San Antonio, Texas 78245-3207
Received for publication, December 21, 1999, and in revised form, March 7, 2000
 |
ABSTRACT |
Rad51-catalyzed DNA strand exchange is greatly
enhanced by the single-stranded (ss) DNA binding factor RPA if the
latter is introduced after Rad51 has already nucleated onto the
initiating ssDNA substrate. Paradoxically, co-addition of RPA with
Rad51 to the ssDNA to mimic the in vivo situation
diminishes the level of strand exchange, revealing competition between
RPA and Rad51 for binding sites on ssDNA. Rad52 promotes strand
exchange but only when there is a need for Rad51 to compete with RPA
for loading onto ssDNA. Rad52 is multimeric, binds ssDNA, and targets
Rad51 to ssDNA. Maximal restoration of pairing and strand exchange
requires amounts of Rad52 substoichiometric to Rad51 and involves a
stable, equimolar complex between Rad51 and Rad52. The Rad51-Rad52
complex efficiently utilizes a ssDNA template saturated with RPA for
homologous pairing but does not appear to be more active than Rad51
when an RPA-free ssDNA template is used. Rad52 does not substitute for
RPA in the pairing and strand exchange reaction nor does it lower the
dependence of the reaction on Rad51 or RPA.
 |
INTRODUCTION |
In eukaryotic organisms, genetic recombination is mediated by
genes of the RAD52 epistasis group. These genes were first
identified in Saccharomyces cerevisiae and consist of
RAD50, RAD51, RAD52, RAD54, RAD55, RAD57, RAD59, RDH54/TID1,
MRE11, and XRS2. Mutations in these genes very often
result in severe meiotic phenotypes including an arrest in meiotic
prophase, low sporulation efficiency, and spore inviability, which
arise because of a requirement for the recombination machinery in
ensuring the proper disjunction of chromosomal homologs in meiosis I. The RAD52 group genes also mediate the repair of DNA strand
breaks by homologous recombination (reviewed in Ref. 1).
The RAD51 gene product is structurally related to RecA
(2-4), which plays a central role in recombination processes in
Escherichia coli. Studies on RecA, its bacteriophage T4
counterpart UvsX, and eukaryotic Rad51 have indicated that they mediate
the homologous DNA pairing and strand exchange reaction that forms
heteroduplex DNA during recombination. In the earliest phase of this
reaction, referred to as presynapsis, Rad51 polymerizes on
ssDNA1 to form a right-handed
nucleoprotein filament that has a highly regular pitch (~95 Å) and
in which the DNA is held in a highly extended conformation (axial rise
of ~5.4 Å per base or base pair) (5, 6). The formation of
heteroduplex DNA with the incoming duplex DNA partner occurs within the
confines of this nucleoprotein filament (6). The assembly of this
presynaptic Rad51-ssDNA nucleoprotein filament requires ATP binding but
not its hydrolysis (7) and is stimulated by the heterotrimeric ssDNA
binding factor RPA, which functions to remove secondary structure in
the ssDNA (8, 9). Human RAD51 also cooperates with human RPA to yield heteroduplex DNA (10, 11).
Maximal level of strand exchange is obtained when RPA is introduced
after Rad51 has already nucleated onto the ssDNA substrate. Paradoxically, a pronounced suppression of the reaction is seen if RPA
is added together with or before Rad51 protein to the ssDNA (12-15).
Rad52 (12, 13, 15) and the heterodimer of the Rad55 and Rad57 proteins
(14) have been found to promote heteroduplex formation when there is a
need for Rad51 to compete with RPA for binding sites on the ssDNA.
These ancillary protein factors, or mediators (15, 16), are
functionally equivalent to the E. coli RecO-RecR complex
(17) and T4 UvsY protein (18-21), which allow their cognate
recombinases RecA and UvsX to gain access to ssDNA already coated with
the ssDNA binding factor. However, the manner in which Rad52 and the
Rad55-Rad57 heterodimer overcome the competition by RPA is not known at
the present time. Here we describe biochemical studies that enable us
to begin understanding the biochemical properties and the mediator
function of Rad52 in greater detail.
 |
MATERIALS AND METHODS |
Purification of Recombination Proteins
Rad52--
E. coli strain M15(pREP4) harboring the
plasmid expressing His6-tagged Rad52 under the control of
the T5 promoter (gift from Rodney Rothstein) (22) was used. Extract was
made from 15 g of cell paste (from 8 liters of culture) in 120 ml
of cell breakage buffer (50 mM Tris-HCl, pH 7.5, 10%
sucrose, 150 mM KCl, 3 mM EDTA, 1 mM 2-mercaptoethanol) in the presence of protease
inhibitors using a French press (23). The lysate was clarified by
centrifugation (100,000 × g, 90 min), and the
supernatant (fraction I, 120 ml) was applied onto a column of
SP-Sepharose (2.5 × 6.1 cm; 30 ml total) equilibrated in buffer K
(20 mM KH2PO4, pH 7.4, 0.5 mM EDTA, 1 mM DTT) containing 150 mM KCl. The column was developed with a 300-ml gradient of
150-650 mM KCl in buffer K. Rad52 elutes from SP-Sepharose
at
360 mM KCl, the pool of which (fraction II, 30 ml)
was diluted with 2 volumes of K buffer and applied to a Q-Sepharose
column (1.5 × 5.5 cm; 8 ml total), which was developed with a
100-ml gradient of 120-450 mM KCl in K buffer, collecting
2-ml fractions. The pool of Rad52 (fraction III; 10 ml), eluting from
Q-Sepharose at about 300 mM KCl, was mixed with 1 ml of
nickel-NTA-agarose (Qiagen) for 2 h at 4 °C. The nickel matrix
was poured into a glass column (1 cm diameter) and washed with 10 volumes each of 10, 20, and 30 mM imidazole in buffer K
containing 500 mM KCl. Rad52 was eluted with 4 ml of 200 mM imidazole in buffer K containing 500 mM KCl
and then concentrated to 1 ml using a Centricon microconcentrator
(Amicon). The concentrated nickel pool (fraction IV) was subject to
sizing in a column of Sepharose 6B (1.6 × 40 cm; 80 ml matrix) in
buffer K containing 150 mM KCl. The Rad52 pool (fraction V,
8 ml) was loaded directly onto a Mono S column (HR5/5), which was
developed with a 30-ml gradient of 150-500 mM KCl in
buffer K. Fractions containing the peak of Rad52 protein, eluting at
350 mM KCl, were pooled (fraction VI; 4 ml) and
concentrated to 5 mg/ml and stored in small portions at
70 °C. The
concentration of Rad52 protein was measured by densitometric comparison
of multiple loadings of Rad52 protein against known amounts of bovine
serum albumin and ovalbumin in a Coomassie Blue R-stained
polyacrylamide gel.
Rad51 Protein--
Rad51 was purified to near-homogeneity from
yeast strain LP2749-9B harboring the plasmid pR51.3 (2 µm,
PGK-RAD51), using a combination of ammonium sulfate
precipitation and chromatographic fractionation steps in columns of
Q-Sepharose, hydroxyapatite, Bio-Rex 70, and Mono Q (7). Rad51 was
stored in K buffer containing 350 mM KCl. The concentration
of Rad51 protein was measured using molar extinction coefficient of
1.29 × 104 M
1
cm
1 at 280 nm (33).
RPA--
RPA was purified from a yeast strain genetically
tailored to co-overexpress the three subunits of RPA (a gift from
Richard Kolodner). Extract was prepared and then subjected to
fractionation in columns of Affi-Gel Blue, ssDNA cellulose,
hydroxyapatite, and Mono Q as described (14). The RPA purified this way
was nearly homogeneous and was stored in K buffer containing 200 mM KCl. The concentration of RPA was measured by
densitometric comparison of multiple loadings of RPA against known
amounts of bovine serum albumin and ovalbumin in a Coomassie Blue
R-stained polyacrylamide gel.
Rad51-Rad52 Complex--
Purified Rad51 (3 mg) and Rad52 (3.25 mg) were incubated in 5 ml of buffer K with 300 mM KCl for
12 h on ice and then mixed with 1 ml of nickel-NTA-agarose to
immobilize the Rad51-Rad52 complex, which was eluted from the nickel
matrix with 3 ml of 200 mM imidazole in buffer K containing
300 mM KCl. The eluate was concentrated to 0.3 ml in a
Centricon-30 microconcentrator, diluted to 3 ml with buffer K
containing 300 KCl, and reconcentrated to 0.3 ml. This filter-dialysis
step was repeated in the same concentrator, and the final concentrate,
containing Rad51-Rad52 complex at 150 µM, was stored in
small portions at
70 °C.
Nucleic Acids
X174 viral (+) strand was purchased from New England Biolabs,
and the replicative form (about 90% supercoiled form and 10% nicked
circular form) was from Life Technologies, Inc. The 83-mer oligonucleotides used in the strand exchange experiments were as
follows: Oligo 1 with 16% GC content, 5'-AAA TGA ACA TAA AGT AAA TAA
GTA TAA GGA TAA TAC AAA ATA AGT AAA TGA ATA AAC ATA GAA AAT AAA GTA AAG
GAT ATA AA; Oligo 2, the exact complement of Oligo 1, was labeled at
the 5' end with [
-32P]ATP by T4 polynucleotide kinase,
and then annealed to Oligo 1. The resulting duplex was purified from
10% polyacrylamide gels by overnight diffusion at 4 °C into TAE
buffer (40 mM Tris-HCl, pH 7.4, 20 mM NaOAC,
0.5 mM EDTA).
Sizing by Gel Filtration
A Sepharose 6B column (1 × 45 cm; 35 ml total) was used to
monitor the migration of Rad51, Rad52, and the Rad51-Rad52 complex in
the experiment described in Fig. 2A. Rad51 protein (11.6 µM in panels I, III, and IV) and
Rad52 protein (11.6 µM in panels II and
III and 2.3 µM in panel IV) were
incubated in 100 µl of column buffer (buffer K containing 150 mM KCl and 1 mM DTT) on ice for 1 h,
diluted with 400 µl of column buffer, and then filtered through the
sizing column at 0.2 ml/min, collecting 0.5-ml fractions. The indicated
column fractions were subject to immunoblot analyses to determine their
content of the Rad51 and Rad52 proteins. For calibration of the column,
thyroglobulin (669 kDa), catalase (232 kDa), and blue dextran (>2,000
kDa) were used, and their elution positions are marked on the
chromatogram in Fig. 2A.
Binding to Nickel-Agarose
In Fig. 2B, Rad51 and Rad52 proteins were incubated
at various molar ratios (0.5 µM Rad51 and 2 µM Rad52 or 1:4; 1.5 µM Rad51 and 1.25 µM Rad52 or 1.2:1; 3 µM Rad51 and 1 µM Rad52 or 3:1; or 2 µM Rad51 alone) in 1 ml of K buffer containing 300 mM KCl and 0.01% Nonidet
P-40 at 4 °C for 1 h. In Fig. 2C, reaction mixtures containing 1.5 µM Rad51 or a combination of 1.5 µM Rad51 and 1.5 µM Rad52 were incubated in
the same buffer with or without 2.5 mM ATP and 3 mM MgCl2 for 1 h. All the mixtures were
gently mixed with 200 µl of nickel-NTA-agarose beads at 4 °C for
3 h. The beads were washed with 2 ml of 20 mM
imidazole in the same buffer with or without ATP/MgCl2
before eluting the bound proteins with 400 µl of 3% SDS by boiling
for 1 min.
DNA Binding
DNA Mobility Shift--
The substrates used were
X174 viral
(+) strand and the replicative form linearized with PstI. In
Fig. 3, A-C, the reactions contained both ssDNA (30 µM nucleotides) and dsDNA (20 µM
nucleotides) with the indicated amounts of Rad51 protein, Rad52
protein, or Rad51-Rad52 complex in 10 µl of reaction buffer (35 mM K-MOPS, pH 7.2, 1 mM DTT, and 100 µg/ml
BSA, with or without 2.5 mM ATP and 3 mM
MgCl2, as indicated). The reaction mixtures were incubated at 25 °C for 10 min, mixed with 2 µl of loading buffer (0.1%
Orange G in 30 mM Tris-HCl, pH 7.5, containing 50%
glycerol), and then subjected to electrophoresis in 0.9% agarose gels
at 100 mA in TAE buffer at 25 °C until the dye front had migrated 4 cm. The gels were stained with ethidium bromide to reveal the DNA species.
Binding to ssDNA Cellulose--
In Fig. 3D, Rad51
(0.45 µM), Rad52 (0.45 µM), or a mixture of
these two proteins in 150 µl of buffer T (20 mM Tris-HCl,
pH 7.5, 10% glycerol, 0.5 mM EDTA, 1 mM DTT,
and 0.01% Nonidet P-40) containing 150 mM KCl and 100 µg/ml BSA was incubated on ice for 45 min and then mixed with 15 µl
of ssDNA cellulose beads (1 µg of denatured calf thymus DNA/µl
beads; purchased from United States Biochemical Corp.) for 45 min at
25 °C. The beads were collected by a 5-s centrifugation in a
microcentrifuge, washed with 150 µl of buffer T containing 300 mM KCl, and treated with 35 µl of 3% SDS at 37 °C for
15 min to elute bound proteins. Equivalent amounts of the input
material, the supernatant that contained unbound proteins, the KCl
wash, and SDS eluate were subject to immunoblotting to examine the
Rad51 and Rad52 contents.
ATPase Assay
Rad51 protein (10 µM) with or without Rad52
protein (4 µM) was incubated with or without
X ssDNA
(30 µM nucleotides) and 1 mM
[
-32P]ATP using the buffer conditions employed in the
strand exchange assay. At the indicated times, 1-µl aliquots were
removed and directly spotted on a polyethyleneimine-cellulose sheet,
which was developed in 0.75 M potassium phosphate. The
polyethyleneimine-cellulose sheets were analyzed in the PhosphorImager.
Homologous Pairing and Strand Exchange
X DNA-based System--
The indicated amounts of Rad51
protein in 1 µl of storage buffer were incubated with ssDNA (30 µM) added in 1 µl of TE buffer (10 mM
Tris-HCl, pH 7.5, 0.2 mM EDTA) in 10 µl of buffer R (35 mM K-MOPS, pH 7.2, 1 mM DTT) containing 50 mM KCl, 2.5 mM ATP, and 3 mM
MgCl2 for 5 min at 37 °C. After the addition of the
indicated amounts of RPA in 0.5 µl of storage buffer, reaction
mixtures were incubated at 37 °C for another 5 min before the
incorporation of dsDNA (30 µM) in 1 µl of TE and 1 µl
of 50 mM spermidine hydrochloride. The reaction mixtures
were incubated at 37 °C and stopped by the addition of an equal
volume of 1% SDS containing 1 mg/ml proteinase K. Deproteinization of
the reaction mixtures was carried out at 37 °C for 20 min. After the
addition of 0.2 volume of gel loading buffer, samples were run in 0.9%
agarose gels in TAE buffer, stained with ethidium bromide for 60 min,
and then destained for at least 4 h in a large volume of
H2O. Images were recorded in a NucleoTech Gel documentation
system and analyzed with the software provided. In the time course
experiments, the reaction mixtures were scaled up accordingly, and
6-µl portions of the mixtures were withdrawn for analysis at each
time point.
Co-addition of Components--
Reaction mixtures (12.5 µl
final volume) containing the indicated amounts of Rad51, Rad52, and RPA
were incubated on ice for 45 min, followed by the addition of
X
ssDNA. The reaction mixtures were then incubated at 37 °C for 10 min, followed by the incorporation of the linear dsDNA and spermidine,
as described in the standard reaction above.
Oligonucleotide-based System--
In Fig. 6A, 1.0 µM Rad51 or Rad51-Rad52 complex was incubated with Oligo
2 (3 µM) in 10.5 µl of buffer R containing 20 mM KCl, 2.5 mM ATP, and 3 mM
MgCl2 at 37 °C for 5 min, followed by the addition of 1 µl of 50 mM spermidine and the homologous duplex (6 µM) consisting of unlabeled Oligo 1 and
32P-labeled Oligo 2 in 1 µl. At the indicated times, 4 µl of the reaction mixture was deproteinized and resolved in a 10%
polyacrylamide gel in TAE buffer, which was dried onto a sheet of DEAE
paper, and the DNA species was quantified in a PhosphorImager. In the experiment in Fig. 7, A and B, unlabeled Oligo 2 (3 µM) was incubated with Rad51 or Rad51-Rad52 complex in
10 µl of buffer R at 37 °C for 5 min before an increasing
concentration of RPA (0.07, 0.14, 0.28, and 0.56 µM) was
added in 0.5 µl. After a further 5 min, 1 µl of 50 mM
spermidine hydrochloride and the homologous 32P-labeled
duplex in 1 µl were incorporated to complete the reactions (12.5 µl
final volume). Alternatively, Oligo 2 was co-incubated in 10.5 µl of
buffer R with RPA and Rad51 or Rad51-Rad52 complex for 5 min or
preincubated with RPA for 5 min before Rad51 or Rad51-Rad52 complex was
added and then followed by an additional 5 min of incubation.
Subsequent to the addition of labeled duplex DNA and spermidine, all
the reaction mixtures (12.5 µl final volume) were incubated at
37 °C for 15 min before being deproteinized and analyzed in 10%
polyacrylamide gels in TAE buffer. The gels were dried and the DNA
species quantified in the PhosphorImager.
Rescue of Strand Exchange with Non-homologous Duplex
All the reaction mixtures in the experiment in Fig. 5 had a
final volume of 37.5 µl. In the experiments in panels I
and II of Fig. 5A, Rad51 protein (10 µM in panel I and 20 µM in
panel II) was preincubated with
X ssDNA (30 µM nucleotides) and then with RPA (1.5 µM)
as in the standard reaction. Following the preincubations, 1 µl of
either TE or TE containing BsaI-linearized pBluescript DNA
(75 µM nucleotides) was added to the reaction mixtures,
which were incubated at 37 °C for another 2 min, before the
X
duplex (30 µM nucleotides) and spermidine were
incorporated to complete the reaction. In the experiment in panel
III of Fig. 5A, Rad51 (10 µM) and Rad52
proteins (2.5 µM) were preincubated with
X ssDNA (30 µM nucleotides) and then with RPA (1.5 µM).
Following these preincubations, 1 µl of either TE or TE containing
linear pBluescript duplex DNA (75 µM nucleotides) was
added to the reaction mixtures, which were incubated at 37 °C for 2 additional min before
X duplex DNA (30 µM nucleotides)
and spermidine were incorporated to complete the reaction. A 6-µl
portion of the reaction mixtures was withdrawn at the indicated times
and processed for gel electrophoresis.
Self-aggregation Assay
Self-aggregation reaction (25 µl final volume) was carried out
by following the order of addition of reaction components and using the
buffer described for the standard strand exchange reaction. After the
addition of dsDNA, reaction samples were incubated at 37 °C for 2 min and immediately spun at 12,000 × g for 2 min at 25 °C. After centrifugation, 20 µl of the supernatant was mixed with 20 µl of 1% SDS, and 35 µl of 0.5% SDS was added to the
pellet fraction to dissolve the precipitated protein-DNA complex. The supernatant and pellet fractions, 8 µl each, were analyzed for their
protein contents by SDS-PAGE and Coomassie Blue staining. To examine
the DNA contents, a 10-µl portion of the supernatant and pellet
fractions was treated with 0.5 mg/ml proteinase K at 37 °C for 20 min and then subjected to agarose gel electrophoresis as described for
the strand exchange experiments. Rad51, RPA, and DNA (ss and ds) were
omitted from some of the experiments (Fig. 6, C and
D), as indicated, and Oligo 2 replaced the
X ssDNA in
Fig. 6E.
 |
RESULTS |
Effects of RPA and Rad52 on Rad51-mediated Strand Exchange--
We
examined the level of strand exchange reaction products (Fig.
1A) by fixing the amount of
Rad51 (10 µM), and we varied the concentration of RPA
(0.4-2.8 µM), added either with Rad51 (Fig. 1B,
panel I) or after Rad51 has already nucleated onto the ssDNA (Fig.
1B, panel II), as in the standard reaction. At levels of RPA
of 2 µM and above, pronounced inhibition of the reaction was observed with the co-addition of components (Fig. 1, B
and C). However, at amounts of RPA lower than 2 µM, the extent of suppression of reaction products was
much less severe (Fig. 1, B and C). It seems
likely that at lower concentrations of RPA, enough Rad51 can still
nucleate onto the ssDNA to prime the assembly of the presynaptic
nucleoprotein filament.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1.
Effect of order of addition of Rad51 and RPA
on the efficiency of homologous DNA pairing and strand exchange.
A, schematic of the homologous DNA pairing and strand
exchange reaction. Pairing between the input X viral (+) strand and
linear duplex yields a joint molecule, which is processed by strand
exchange to produce the final products, nicked circular duplex and
displaced ssDNA. B, increasing amounts of RPA (0, 0.4, 0.8, 1.2, 1.6, 2, 2.4, and 2.8 µM in lanes 2-9,
respectively) was added together with Rad51 protein to the ssDNA
(I) or to preformed Rad51-ssDNA nucleoprotein filament
(II). After the incorporation of linear duplex DNA, reaction
mixtures were incubated for 40 min before being deproteinized and
analyzed by agarose gel electrophoresis to examine the level of pairing
and strand exchange products. The concentrations of the other reactants
were as follows: Rad51, 10 µM; ssDNA, 30 µM
nucleotides; dsDNA, 30 µM nucleotides. jm,
joint molecules; nc, nicked circular duplex; ds,
input linear duplex; ss, viral (+) strand and displaced
linear (+) strand. C, graphical representation of the
results shown in B. , level of products obtained in the
reaction wherein Rad51 and RPA were added to ssDNA at the same time, as
shown in panel I of B; , level of products
obtained in the standard reaction as shown in panel II of
B. D, strand exchange reactions in which Rad51
(10 µM) and RPA (2 µM) were added together
to the ssDNA (30 µM) either without ( ) or with ( )
Rad52 protein (1.2 µM). The results from a standard
reaction in which the ssDNA was preincubated with Rad51 are also
plotted ( ) for reference. The concentration of dsDNA was 30 µM nucleotides in all the incubations.
|
|
We have previously described expression of Rad52 in yeast and its
purification to near-homogeneity (15). Since much larger amounts of
functionally active and nearly homogeneous Rad52 can be obtained by
expression in E. coli (12, 13, 22), we have since used the
E. coli system for purifying Rad52 (22). As indicated from
recent work (12, 13, 15) and reiterated here (Fig. 1D), the
addition of Rad52 at an amount substoichiometric (1.2 µM)
to that of Rad51 (10 µM) restored strand exchange to a
level comparable to what was obtained in the standard reaction (Fig. 1D). Rad52 by itself, with or without RPA, is devoid of
homologous DNA pairing activity (12, 13, 15).
Rad52 Is Multimeric and Forms a Stable, Stoichiometric Complex with
Rad51--
As shown in Fig. 2A,
panel I, Rad51 (43 kDa) eluted from a Sepharose 6B column with an
average Ve/Vt (elution volume/total column volume) of ~0.7, which is slightly before the
elution position of catalase (232 kDa), suggesting a multimeric structure under the conditions used. Rad52 (56 kDa) eluted from Sepharose 6B with an average
Ve/Vt of ~0.6, slightly before
the elution volume of thyroglobulin (669 kDa), indicating that Rad52
also exists as a multimeric structure (Fig. 2A, panel II);
the same results were obtained with Rad52 purified from yeast cells
(data not shown).

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 2.
A stable, stoichiometric complex of Rad51 and
Rad52. A, complex formation revealed by sizing. Rad51
protein (I) and Rad52 protein (II) were filtered
through a column of Sepharose 6B. In the experiment in panel
III, equimolar amounts of Rad51 and Rad52 proteins were mixed,
incubated on ice for 1 h, and then filtered, and in panel
IV, a mixture of Rad52 and 5 molar excess of Rad51 was incubated
on ice for 1 h and then filtered. Identification of the protein
peaks was done by immunoblotting of the column fractions. To calibrate
the sizing column, a mixture of thyroglobulin (TG; 669 kDa)
and catalase (CAT; 232 kDa) was filtered. The column void
was determined by filtering dextran blue (DB; >2,000 kDa).
I, the input material. B, complex formation
revealed by binding to nickel-agarose. Rad51 alone, Rad51 with 4 molar
excess of Rad52 (1:4), 1.2 molar excess of Rad51 with Rad52 (1.2:1),
and 3 molar excess of Rad51 with Rad52 (3:1) were incubated with
nickel-NTA-agarose, and bound proteins were eluted with SDS. The input
materials (I) and the SDS eluates (E) were run in
a 10% denaturing polyacrylamide gel followed by staining with
Coomassie Blue. C, ATP has no measurable effect on complex
formation. Rad51 alone, or a mixture of Rad51 and Rad52 at equimolar
ratio, was mixed with nickel-agarose in buffer that contained ATP and
magnesium or with the ATP and magnesium omitted, and the bound proteins
were analyzed as described in B.
|
|
When mixed with an equimolar amount of Rad52, the majority of Rad51
(>85%) emerged from the sizing column at a much earlier position
(average Ve/Vt of ~0.55) than
free Rad51 (Ve/Vt of ~0.7).
Consistent with the formation of a stable complex of Rad51 and Rad52,
the Rad52 peak was also shifted slightly (Fig. 2A, panel
III). When the amount of Rad52 was lowered to one-fifth of the
previous level, the portion of the Rad51 shifted to the earlier elution
position dropped accordingly to about 20% of the total (see Fig.
2A, panel IV). Similarly, when Rad52 was fixed at the
previous level but with the amount of Rad51 being increased five times,
the portion of Rad51 found in association with Rad52 was once again
about 20% of the total (data not shown). Thus, Rad51 and Rad52 form a
stable complex consisting of approximately equimolar amounts of the two
proteins. Judging from the elution position of the Rad51-Rad52 complex, it appears that the complex contains multiple molecules of the two proteins.
Complex formation between Rad51 and Rad52 was also examined by mixing
different molar amounts of the two proteins and then immobilizing the
complex on nickel-NTA-agarose through the histidine tag on Rad52. The
results shown in Fig. 2B are again consistent with an
approximately equimolar complex between Rad51 and Rad52. The addition
of ATP and magnesium did not alter the amount or the stoichiometry of
Rad51-Rad52 complex formed, assessed both by immobilizing the complex
via the histidine tag on Rad52 (Fig. 2C) or by sizing in
Sepharose 6B (data not shown).
Rad52 Targets Rad51 to ssDNA--
The same molar concentrations of
Rad51, Rad52, and Rad51-Rad52 complex were incubated with a mixture of
ssDNA and dsDNA in the presence of ATP and magnesium, and nucleoprotein
complexes were separated from free DNA in an agarose gel and visualized by staining with ethidium bromide. Fig.
3A shows that both Rad52 and
the Rad51-Rad52 complex bound specifically to the ssDNA. The experiment
presented in Fig. 3A was done in the presence of ATP and
magnesium, but we have detected no difference in terms of the amount of
ssDNA shifted or the binding specificity of the Rad51-Rad52 complex
when ATP was omitted from the reaction mixture (Fig. 3B). No
significant shifting of either the ss or ds form of DNA was observed
with the concentrations of Rad51 used (Fig. 3A). Much higher
concentrations of Rad51 are needed to see ATP-dependent binding to the ssDNA and dsDNA (Fig. 3C).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3.
Rad52 targets Rad51 to ssDNA.
A, DNA mobility shift experiments that used a mixture of
ssDNA (30 µM nucleotides) and dsDNA (20 µM
nucleotides) and increasing concentrations of Rad51, Rad52, and
pre-assembled Rad51-Rad52 complex (0.05 µM in lanes
2, 6, and 10; 0.1 µM in lanes 3, 7, and 11; 0.2 µM in lanes 4, 8, and 12; 0.3 µM in lanes 5, 9, and 13) in reaction buffer that contained ATP and
magnesium. B, Rad51-Rad52 complex (0.2 µM in
lanes 2, 6, and 10; 0.3 µM in
lanes 3, 7, and 11; 0.4 µM in
lanes 4, 8, and 12; 0.5 µM in
lanes 5, 9, and 13) was incubated with ssDNA (30 µM nucleotides) and dsDNA (20 µM
nucleotides) in buffers that contained ATP and magnesium (lanes
2-5), with magnesium only (lanes 6-9), or with both
ATP and magnesium omitted (lanes 10-13), as indicated.
C, DNA mobility shift experiments that used a mixture of
ssDNA (30 µM nucleotides) and dsDNA (20 µM
nucleotides) and an increasing concentration of Rad51 (2 µM in lanes 2, 6, and 10; 4 µM in lanes 3, 7, and 11; 6 µM in lanes 4, 8, and 12; 8 µM in lanes 5, 9, and 13), done in
buffers that contained ATP and magnesium (lanes 2-5), with
magnesium only (lanes 6-9), or with both ATP and magnesium
omitted (lanes 10-13), as indicated. D, binding
of Rad51 protein to ssDNA cellulose via complex formation with Rad52.
Rad51, Rad52, and the Rad51-Rad52 complex (0.45 µM each)
were mixed with ssDNA cellulose, which was washed with 300 mM KCl, and then treated with 3% SDS to elute bound
proteins. The content of Rad51 and Rad52 in the various fractions was
determined by immunoblot analysis. I, input material;
S, supernatant after mixing with ssDNA cellulose;
W, the KCl wash; E, SDS eluate.
|
|
In the DNA mobility shift experiments (Fig. 3, A and
B), we could not ascertain that Rad51 was present in the
nucleoprotein complex. To demonstrate directly that Rad51 is being
targeted to ssDNA by Rad52, we co-incubated Rad51 and Rad52 with ssDNA cellulose and then analyzed the bound proteins by immunoblot analyses after their elution from the matrix by SDS treatment. Under the same
conditions, Rad51 alone did not bind to ssDNA cellulose, but Rad52
alone did (Fig. 3D). Importantly, very similar amounts of
Rad51 and Rad52 proteins were found in the ssDNA cellulose eluates,
indicating that Rad51 bound along with Rad52 to the ssDNA on the
matrix. In these experiments, ATP and magnesium were added to all the
buffers used. However, the same results were obtained when either ATP
or magnesium was omitted from the buffers (data not shown). Taken
together, the results suggest that Rad51 is being targeted to ssDNA via
complex formation with Rad52.
Excessive Rad52 Inhibits DNA Strand Exchange--
Interestingly,
quantities of Rad52 in excess of what was required to give maximal
restoration of strand exchange in fact resulted in pronounced
inhibition of the reaction. Specifically, at 3 µM Rad52,
the level of reaction products was reduced more than 10-fold compared
with the maximally restored level (Fig.
4, A and B). This
inhibitory effect of Rad52 was also seen in experiments wherein RPA was
incorporated after a preincubation of Rad51 and Rad52 with the ssDNA
template (data not shown).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Opposite effects of Rad52 on DNA strand
exchange. A, strand exchange reactions in which Rad51
(10 µM), RPA (2 µM), and increasing
concentrations of Rad52 protein (0, 0.25, 0.5, 1, 1.5, 2, 2.5, and 3 µM in lanes 2-9, respectively) were
preincubated on ice 45 min and added together to the ssDNA (30 µM nucleotides). After the incorporation of the dsDNA (30 µM nucleotides), the reaction mixtures were incubated for
60 min. The 60-min time point of a standard strand exchange reaction is
also shown (lane 10; Std). jm, joint
molecules; nc, nicked circular duplex; ds, input
linear duplex; ss, viral (+) strand and displaced linear (+)
strand. B, the results in A are plotted.
C, Rad51 protein (10 µM) without ( ) or with
4 µM Rad52 protein ( ) were assayed for ATPase activity
in the presence of ssDNA (30 µM nucleotides). ATP
hydrolysis by Rad51 without ( ) or with 4 µM Rad52
protein ( ) was also examined in the absence of ssDNA.
|
|
We considered the possibility that the suppression of strand exchange
by excessive Rad52 might have been due to an exclusion of Rad51 from
the ssDNA substrate. Since Rad52 by itself has no ATPase activity and
the ssDNA-dependent ATPase activity of Rad51 provides a
reliable means for estimating the level of Rad51-ssDNA nucleoprotein
filament (8), we measured the Rad51-mediated ssDNA-dependent ATP hydrolysis in the presence of
increasing amounts of Rad52 protein; the results of this experiment are
shown in Fig. 4C. We found that an amount of Rad52 (4 µM) that would result in almost complete inhibition of
pairing and strand exchange did not cause any noticeable inhibition of
the Rad51 ATPase activity, strongly suggesting that Rad51 can still
gain access to the ssDNA even when Rad52 is present in excess.
Consistent with this deduction, we have found that a preassembled
Rad51-Rad52 complex shows the same level of ssDNA-dependent
ATPase activity as free Rad51 (data not shown).
Rad51 above the level of three nucleotides per protein monomer inhibits
strand exchange by binding the duplex molecule (6), and this inhibition
is effectively reversed by the addition of the unrelated pBluescript
dsDNA to the reaction (Fig. 5,
panel II in A and B). Since Rad52 also
binds dsDNA, albeit with a much lower affinity than binding to ssDNA
(Ref. 24, Fig. 3A), we thought it was possible that the
inhibition of strand exchange by excessive Rad52 might have been due to
coating of the dsDNA by Rad52. However, the addition of a relatively
large amount of pBluescript dsDNA to reaction mixtures containing an
inhibitory level of Rad52 did not restore strand exchange (Fig. 5,
panel III in A and B; data not shown).
We also considered the possibility that an excess of Rad52 may bind to
and sequester RPA from the ssDNA, as an interaction between Rad52 and
RPA has been described (24, 25). However, increasing the RPA
concentration to exceed that of Rad52 was also completely ineffective
in restoring strand exchange, regardless of whether the excess of RPA
was added with Rad51 and Rad52 to the ssDNA or after a preincubation of
Rad51 and Rad52 with the ssDNA (data not shown).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 5.
Inhibition by excessive Rad52 cannot be
overcome by heterologous dsDNA. A, panel I, time course
of strand exchange reactions in which Rad51 (10 µM) was
preincubated with ssDNA (30 µM) and then with RPA (1.5 µM) before the homologous dsDNA (30 µM
nucleotides) was added. In lanes 6-9, 2 min prior to the
incorporation of the homologous dsDNA, pBluescript dsDNA (75 µM nucleotides) was added to the reaction mixture.
Panel II, strand exchange reactions were set up exactly as
described in panel I, except that the concentration of Rad51
protein was increased to 20 µM. Panel III,
strand exchange reactions were set up as described in panel
I, except that 2.5 µM Rad52 was added with Rad51 to
the ssDNA. jm, joint molecules; nc, nicked
circular duplex; ds, input linear duplex; ss,
viral (+) strand and displaced linear (+) strand; pBS,
pBluescript linear dsDNA. B, the results in panels
I-III in A are plotted in panels I-III,
respectively. , reactions without pBluescript DNA; , reactions
with pBluescript DNA.
|
|
Inhibition by Rad52 Is Likely Due to Intramolecular
Aggregation--
One possible explanation for the inhibition seen
(Figs. 4A and 5A) was that Rad51-Rad52 complex
was inactive in DNA strand exchange and that an excess of it could
impair the functionality of the nucleoprotein filament. If this was the
cause of inhibition seen with the
X substrates, then the complex of
Rad51-Rad52 should be inactive in the strand exchange system that
employs oligonucleotide-based substrates. To test directly this idea,
we assembled and purified the Rad51-Rad52 complex (see "Experimental
Procedures") and then compared its ability to promote strand exchange
between oligonucleotide-based substrates to that of Rad51.
Surprisingly, the Rad51-Rad52 complex was just as active as free Rad51
in promoting strand exchange between the oligonucleotide-based
substrates, regardless of whether relatively low concentrations of
reactants (3 µM ssDNA, 6 µM dsDNA, 1 µM Rad51 or Rad51-Rad52 complex, as shown in Fig.
6A) or 10 times higher
concentrations of reactants were used (data not shown). These results
indicate that there is no functional deficit in the Rad51-Rad52 complex
compared with free Rad51 in strand exchange activity.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Rad52 inhibits X
DNA-based strand exchange via intramolecular
aggregation. A, Rad51-Rad52 complex is active in strand
exchange using oligonucleotide substrates. Rad51 or Rad51-Rad52
complex, 1 µM each, was incubated with the
oligonucleotide substrates for the indicated times. Strand exchange
between the unlabeled oligonucleotide (3 µM nucleotides)
and the 32P-labeled homologous duplex (6 µM
nucleotides) yields a radiolabeled oligonucleotide (displaced ss),
which was resolved from the duplex by electrophoresis in a
polyacrylamide gel and visualized by autoradiography of the dried gel
in I. The gel was also subject to phosphorimage analysis to
yield data points for the graph in II. Symbols used in
panel II: , reaction with Rad51; , reaction with
Rad51-Rad52 complex. B, aggregation of X ssDNA, Rad51,
and Rad52. Strand exchange reactions with final volumes of 25 µl
containing ssDNA (30 µM nucleotides), dsDNA (30 µM nucleotides), RPA (2 µM), Rad51 (10 µM), and with no Rad52 (lanes 1 and
2), 1.3 µM Rad52 (lanes 3 and
4), or 3 µM Rad52 (lanes 5 and
6) were incubated at 37 °C for 2 min and then centrifuged
at 12,000 × g for 2 min at 25 °C. After
centrifugation, 20 µl of the supernatant (S) was mixed
with an equal volume of 1% SDS, whereas the material that remained in
the tubes was mixed with 35 µl of 0.5% SDS and designated the pellet
fraction (P). Portions of these fractions were analyzed by
agarose gel electrophoresis for their DNA contents (I) and
by SDS-PAGE for their protein contents (II), as shown.
C, Rad52-mediated aggregation is DNA-dependent.
Reactions containing Rad51 (10 µM), Rad52 (3 µM), RPA (2 µM), and with or without ssDNA
(30 µM nucleotides) were assayed for aggregation. The
supernatant (S) and pellet (P) fractions were
analyzed for their protein contents. D, aggregation occurs
with Rad52 alone and is DNA-dependent. Reaction mixtures
containing 3 µM Rad52 protein and ssDNA (30 µM nucleotides) were assayed for aggregation. Symbols are
the same as in C. E, aggregation does not occur
with an oligonucleotide. Rad51 (10 µM), Rad52 (3 µM), and RPA (2 µM) were incubated with or
without Oligo 2 (30 µM nucleotides), centrifuged, and the
supernatant (S) and pellet (P) fractions were
analyzed for their protein contents. B, C, and E,
only the largest subunit of RPA is shown.
|
|
As expected, purified Rad51-Rad52 complex was completely inactive in
the strand exchange system that employs
X DNAs, with or without RPA
(data not shown). Thus, it appears that the inhibitory effect of Rad52
on strand exchange is specific for long DNA molecules, as we did not
observe strand exchange inhibition with short oligonucleotide substrates (Fig. 6A). Because of this observation, we
considered the possibility that perhaps multimers of Rad52 have a
tendency to interact with one another, thereby sequestering Rad51 and
ssDNA through intramolecular aggregation. Indeed, when reaction
mixtures containing increasing amounts of Rad52 were spun for a brief
time in a bench top centrifuge, we found a Rad52
concentration-dependent aggregation of Rad51, Rad52, and
ssDNA in a form recoverable in the bottom of the Eppendorf tubes (Fig.
6B). At 3 µM Rad52 (10 nucleotides per Rad52
monomer), where complete inhibition of strand exchange occurs,
essentially all of the ssDNA and Rad51 co-aggregated with Rad52,
whereas the expected amount of the duplex DNA remained in the
supernatant (Fig. 6B, lanes 5 and 6). The amount
of RPA that co-aggregated with the other reaction components varied
between experiments but in general was much less than the amount of
co-aggregating Rad51, Rad52, and ssDNA. The aggregation seen was
induced by binding of Rad52 to the ssDNA because (i) in the absence of
ssDNA the protein components remained in the supernatant after
centrifugation (lanes 1 and 2 in Fig. 6,
C and D), (ii) Rad52 by itself underwent DNA-dependent aggregation (lanes 3 and
4 in Fig. 6D), and (iii) Rad51, with or without
RPA, did not undergo aggregation (lanes 1 and 2 in Fig. 6B, data not shown).
We have also examined whether relatively high amounts of Rad52 would
inhibit strand exchange when the concentrations of the reactants were
one-third those used in Fig. 6B. In these experiments, Rad52
again inhibited strand exchange when its concentration exceeded a ratio
of 15 nucleotides per protein monomer, resulting in Rad51-Rad52-ssDNA aggregates that were readily pelleted by a brief spin in a
microcentrifuge (data not shown). As expected, incubation of
concentrations of Rad52 protein and the oligonucleotide used in strand
exchange experiments did not result in aggregate formation (Fig.
6E), confirming that Rad52-mediated co-aggregation of Rad51
and ssDNA occurs efficiently only with long DNA molecules and that this
aggregation results in inactivation of strand exchange.
Rad51-Rad52 Complex Can Utilize a Template Coated with RPA for
Homologous Pairing--
The fact that Rad51-Rad52 complex is active in
DNA strand exchange on oligonucleotide-based DNA substrates allows us
to test whether or not it has the ability to utilize a template that is already saturated with RPA for pairing with the homologous duplex. For
this purpose, we first carried out a titration experiment in which a
fixed amount of ss oligonucleotide had been incubated with increasing
concentrations of RPA before being mixed with Rad51 and the homologous
duplex. The results from this experiment indicated that at a ratio of
20 nucleotides per RPA monomer, inhibition of homologous DNA pairing
occurred (Fig. 7A), which is
consistent with the result obtained using full-length
X DNA (Fig.
1). As shown in Fig. 7B, when the Rad51-Rad52 protein
complex was added to the oligonucleotide template precoated with RPA, a
pairing reaction as robust as the ones that used either Rad51 or
Rad51-Rad52 complex without RPA was seen. Since Rad51 alone is
incapable of utilizing RPA-coated oligonucleotide for strand exchange,
these results suggest that the Rad51-Rad52 complex has the ability to displace bound RPA off the DNA template.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 7.
Rad51-Rad52, but not Rad51, can utilize an
RPA-coated ssDNA template for homologous pairing. A,
homologous pairing reactions that used oligonucleotides (3 µM ss and 6 µM homologous duplex) with
Rad51 protein (1 µM), in which increasing concentrations
of RPA (0.07, 0.14, 0.28, and 0.56 µM) were either
preincubated with the ss oligonucleotide ( ), added with Rad51 to the
ss oligonucleotide ( ), or added after the ss oligonucleotide had
been preincubated with Rad51 ( ). B, Rad51-Rad52 complex
(1 µM) and oligonucleotide substrates (3 µM
ss and 6 µM homologous duplex) were used in the strand
exchange reactions. In these reactions, increasing concentrations of
RPA (0.07, 0.14, 0.28, and 0.56 µM) were either
preincubated with the ss oligonucleotide ( ), added with Rad51-Rad52
complex to the ss oligonucleotide ( ), or added after the ss
oligonucleotide had been preincubated with Rad51-Rad52 complex ( ).
After the addition of the 32P-labeled duplex, reaction
mixtures were further incubated at 37 °C for 15 min. The reaction
mixtures were resolved in 10% polyacrylamide gels, and the reaction
products were quantified in the PhosphorImager.
|
|
Co-incubation of Rad51 and RPA also resulted in inhibition of the
pairing reaction mediated by Rad51, although not to the same extent as
when RPA was preincubated with the ssDNA substrate (Fig.
7A). As expected, RPA did not inhibit homologous pairing when added together with the Rad51-Rad52 complex to the ssDNA substrate
(Fig. 7B) or added after Rad51 has already nucleated onto
the oligonucleotide (Fig. 7A).
Rad52 Does Not Replace RPA nor Does It Lower the Dependence of
Strand Exchange on RPA and Rad51--
Human Rad52 enhances the
efficiency of homologous DNA pairing when human RPA is absent and human
Rad51 is limiting relative to the ssDNA (26). To examine whether yeast
Rad52 would exert a similar stimulatory effect on yeast Rad51, we fixed
the quantity of the ssDNA and used a wide range of Rad51 concentrations
from ratios of 7.5 nucleotides/protein monomer to 1.9 nucleotides/protein monomer, with or without Rad52 at below the optimal
level to above the optimal level for its mediator function. As shown
previously (6), elevating the level of Rad51 up until three nucleotides per Rad51 monomer results in increasing extent of pairing and strand
exchange, whereas exceeding this amount of Rad51 results in progressive
inhibition (Fig. 8, A and
B). Unexpectedly, at and above Rad52 levels optimal for its
mediator function, a highly significant depression of pairing and
strand exchange occurred at the lower concentrations of Rad51 (Fig.
8A, panels III and IV). Thus, Rad52 actually
suppresses the strand exchange reaction at low concentrations of Rad51,
a result opposite to that observed for human RAD51 and RAD52 (26).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Effects of Rad52 on the dependence of strand
exchange on Rad51. A, panel I shows strand exchange
reactions in which increasing concentrations of Rad51 protein (4, 6, 8, 10, 12, and 16 µM in lanes 2-7, respectively)
were preincubated with ssDNA (30 µM nucleotides) before
the incorporation of RPA (1.5 µM), followed by dsDNA (30 µM nucleotides). The reactions in panels
II-IV were set up exactly as described for panel I,
except that 0.8, 1.2, and 1.8 µM Rad52 was added with
Rad51 to the ssDNA in II-IV, respectively. The reaction
time for these strand exchange experiments was 60 min. jm,
joint molecules; nc, nicked circular duplex; ds,
input linear duplex; ss, viral (+) strand and displaced
linear (+) strand. B, the results shown in A are
plotted: , results in I; , results in II;
, results in III; , results in IV.
|
|
In the absence of RPA, the level of joint molecules increased from
~5% after 90 min of reaction with Rad51 alone to ~11% in the
presence of 1.2 µM Rad52, and the amount of nicked
circular duplex also increased from less than 1 to 3% at this amount
of Rad52 (Fig. 9, A and
B). The stimulation of Rad51 strand exchange activity by
Rad52 is insignificant compared with that afforded by RPA.
Interestingly, in the absence of RPA, concentrations of Rad52 at 2 µM and above also resulted in progressive inhibition of
the reaction, such that at 3.2 µM Rad52, little reaction
product was seen (Fig. 9, A and B). As shown
earlier (Fig. 6), the inhibition of strand exchange is due to
intramolecular aggregation mediated by Rad52. We have also investigated
whether Rad52 would lessen the dependence of the pairing and strand
exchange reaction on RPA (Fig. 9, C and D), but
we have found that Rad52 at a level optimal for its mediator function
has no measurable effect on the RPA requirement (Fig. 9C, panel
II), and higher Rad52 amounts progressively inhibit strand
exchange at all concentrations of RPA tested (Fig. 9C, panel
III; data not shown).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 9.
Rad52 and RPA serve distinct roles in strand
exchange. A, Rad52 does not replace RPA. Rad51 protein
(10 µM) and increasing concentrations of Rad52 protein
(0, 0.8, 1.2, 1.6, 2.0, 2.4, 2.8, and 3.2 µM in
lanes 2-9, respectively) were used in strand exchange
reactions without RPA. The Rad51 and Rad52 proteins were preincubated
on ice for 45 min before the ssDNA was incorporated. The incubation
time for this experiment was 90 min. The 60-min time point from a
standard reaction in which Rad51 was preincubated with ssDNA without
Rad52 followed by the addition of RPA is shown in lane 10 for comparison. jm, joint molecules; nc, nicked
circular duplex; ds, input linear duplex; ss,
viral (+) strand and displaced linear (+) strand. B, the
results in lanes 2-9 of A are plotted.
C, Rad52 does not lower dependence of strand exchange on
RPA. Panel I, Rad51 protein (10 µM) was
preincubated with ssDNA (30 µM nucleotides) before the
incorporation of increasing concentrations of RPA (0.2, 0.4, 0.6, 0.8, 1, and 1.2 µM in lanes 2-7, respectively),
followed by dsDNA (30 µM nucleotides). The reactions in
panels II and III were set up exactly as
described for panel I, except that 1.2 and 1.8 µM Rad52 protein was added with Rad51 to the ssDNA in
II and III, respectively. The reaction time for
these strand exchange experiments was 45 min. jm, joint
molecules; nc, nicked circular duplex; ds, input
linear duplex; ss, viral (+) strand and displaced linear (+)
strand. D, the results shown in C are plotted:
, results in I of C; , results in
II of C; and , results in III of
C.
|
|
 |
DISCUSSION |
Rad52 as Mediator of Strand Exchange--
Since the
RAD52 gene is indispensable for recombination and the Rad52
protein interacts with Rad51 in a two-hybrid system (27) and in
vitro (Refs. 4 and 15 and this work), it seems possible that Rad52
protein may help overcome the competition posed by RPA for binding to
ssDNA. Consistent with this idea, the inclusion of Rad52 protein in a
pairing and strand exchange reaction neutralizes the inhibitory effect
of RPA (12, 13, 15). New et al. (12) have also demonstrated
that a RecA-mediated strand exchange reaction is in fact inhibited by
the inclusion of Rad52 protein. Taken together, the biochemical studies
have indicated that Rad52 protein fulfills the role of a molecular mediator, functionally linking the Rad51 recombinase and the ssDNA binding factor RPA (15, 16).
The results from our immunoprecipitation studies have revealed that (i)
Rad52 is of lower abundance than Rad51 protein, (ii) the majority or
maybe all of the cellular Rad52 protein is associated with Rad51, and
(iii) the majority of cellular Rad51 is in fact free from Rad52 (15).
In apparent congruence with the immunoprecipitation data, we have
demonstrated that in mediating the reversal of inhibition by RPA,
amounts of Rad52 protein substoichiometric to that of Rad51 are already
sufficient for the full restoration of pairing and strand exchange. We
have presented results from sizing experiments that indicate a
multimeric nature of Rad52 protein and that the Rad52 multimer forms a
stable, approximately equimolar complex with Rad51 protein. Since
maximal mediator activity is seen at Rad52 amounts about one-seventh to
one-tenth that of Rad51, we deduce that perhaps only a small fraction
of Rad51 is stably associated with Rad52 protein under conditions of
maximal restoration of DNA strand exchange.
Rad52 binds both ssDNA and dsDNA but shows higher affinity for ssDNA
(Refs. 22 and 24, Fig. 3A). Whereas free Rad51 protein by
itself requires ATP to bind to DNA, with apparently an equal affinity
for ssDNA and dsDNA, the Rad51-Rad52 complex does not need ATP to bind
DNA and appears to show a much higher affinity for ssDNA than dsDNA. It
is apparent that in the presence of ATP, Rad51 is in contact with the
DNA, as indicated by a normal level of ATPase activity (Fig.
4C). However, we do not yet know whether actual loading of
Rad51 present in the Rad51-Rad52 complex to the ssDNA requires ATP
binding and hydrolysis and whether upon binding of Rad51 to the ssDNA,
Rad52 is displaced off the DNA substrate.
Although Rad52 protein enhances the level of pairing and strand
exchange reaction products in the absence of RPA, even the maximally
stimulated level is rather insignificant compared with what can be
achieved with RPA (Fig. 9). The results from other related experiments
have also indicated that the presence of Rad52 protein does not alter
the amount of RPA required for maximal pairing and strand exchange
(Fig. 9, C and D), thus eliminating the
possibility Rad52 might have acted synergistically with RPA in the
removal of secondary structure in the ssDNA substrate. We also
considered the possibility that Rad52 protein may in fact lessen the
reliance of the DNA strand exchange reaction on the Rad51 protein,
especially that such an effect of human Rad52 on the equivalent
reaction mediated by the human RAD51 protein has recently been reported
by Benson et al. (26). In contrast to what has been observed
with the equivalent human recombination factors, not only that yeast
Rad52 does not lower the dependence of strand exchange on Rad51, it in
fact suppresses this reaction significantly at suboptimal
concentrations of Rad51 protein (Fig. 8, A and
B). At suboptimal levels of Rad51 and without Rad52, we
suspect that Rad51 could bind cooperatively to some of the ssDNA
molecules and thus assemble into a limited number of functional presynaptic filaments. In the presence of Rad52 protein, however, the
Rad51-Rad52 complex may nucleate randomly onto all of the ssDNA
molecules and prime the assembly of partial Rad51 filaments that have
only a limited ability to mediate pairing and strand exchange.
Recently, an inverse DNA strand exchange reaction mediated by a
RecA-dsDNA complex was reported (34). We have examined the possibility
that Rad52 protein bound to a ss oligonucleotide may function with a
Rad51-ds oligonucleotide complex in a similar inverse strand exchange
reaction. The results indicate that the nucleoprotein complex of Rad51
with ds oligonucleotide has at most a low level of strand exchange
activity. More importantly, Rad52 prebound to ssDNA in fact suppresses
this already negligible level of strand exchange
further.2 Although the
results do not eliminate the possibility that Rad51 could promote
limited inverse strand exchange, they indicate that Rad52 bound to
ssDNA does not enhance a possible inverse strand exchange reaction. We
have also tested whether Rad52 prebound to a ds oligonucleotide would
enhance strand exchange with the Rad51-ss oligonucleotide complex. The
results indicate that Rad52 suppresses strand exchange when bound to
duplex oligonucleotide.2
How May Rad52 Work?--
Thus, Rad52 and RPA fulfill highly
specialized functions in Rad51-mediated strand exchange, with RPA
acting primarily to melt secondary structure in the ssDNA template and
Rad52 functioning to facilitate Rad51-ssDNA nucleoprotein filament
assembly when RPA is competing for binding sites on the template.
Collectively, the results suggest that a preassembled, multimeric
complex consisting of Rad51 and Rad52 binds to available sites on the
ssDNA substrate, and we speculate that the DNA-bound Rad51-Rad52
complex could play two distinct roles to maximize the likelihood of
assembling a functional presynaptic filament. First, the Rad51-Rad52
complex could displace RPA from the ssDNA within the vicinity of its
initial loading site(s). Second, the stably bound Rad51-Rad52 complex could provide a priming effect for the recruitment of free Rad51 molecules. The growing chain of Rad51 protein filament then gradually displaces the bound RPA molecules in its path without additional assistance from Rad52 protein. It seems reasonable to suggest that the
multimeric structure of Rad52 protein is relevant for its mediator
function. Possibly, the oligomeric structure noted enables Rad52
protein and the Rad51-Rad52 complex to make multiple contacts with the
DNA, resulting in a higher affinity of these protein species for DNA
and enhanced stability of the nucleoprotein complexes that form. In
addition, it is conceivable that the oligomeric structure helps ensure
that one single nucleation event will lead to the loading of multiple
Rad51 molecules onto the ssDNA, thus maximizing the chance for the
assembly of a nascent Rad51 filament.
Interestingly, the mediator function of Rad52 described here is very
familiar to those of UvsY in bacteriophage T4 and RecO-RecR complex
in E. coli. These prokaryotic recombination factors promote the assembly of the recombinase-ssDNA nucleoprotein filament by overcoming the inhibition of an ssDNA-binding protein. The conservation of function of these mediators across divergent species is consistent with their importance in recombination (28).
Our studies have indicated that the complex of Rad55 and Rad57 proteins
also functions as a mediator during the presynaptic phase of the
pairing and strand exchange reaction. Whereas Rad52 is multimeric and
associates stably with Rad51, Rad55-Rad57 is heterodimeric and
interacts only weakly with Rad51 (14). Rad55-Rad57 heterodimer may act
via a different mechanism or it may assist Rad51 at a stage in the
assembly of the presynaptic filament temporally distinct from the
reaction step that is dependent on Rad52.
RAD52-specific Recombination--
In addition to functioning as a
mediator in Rad51-mediated homologous DNA pairing and strand exchange,
Rad52 protein also mediates the annealing of complementary single
strands (22) in a reaction that is accelerated by RPA (24, 25). The DNA strand annealing activity of Rad52 is likely to be relevant for its
involvement in the single-strand annealing pathway of
deletion-associated recombination between direct DNA repeats (see Ref.
29 for a discussion). Rad52 is also involved in a long tract gene
conversion pathway known as break-induced replication or BIR (30, 31). In BIR, a heteroduplex DNA joint is formed between an initiating single-strand and a duplex donor molecule at a region of homology, to
prime DNA synthesis for copying the genetic information in the donor
DNA molecule. Whether or not the ssDNA annealing activity of Rad52 is
utilized for making the heteroduplex joint in BIR remains to be
determined. Recently, Van Dyck et al. (32) reported that
human RAD52 protein binds specifically to the ssDNA tail portion of a
partially duplex DNA molecule, consistent with the postulated role of
Rad52 in promoting the utilization of the ssDNA tail arising from the
end-processing reaction for recombination events in
vivo.
 |
ACKNOWLEDGEMENTS |
Michael Cox and Aimee Eggler are gratefully
acknowledged for their critical reading of the manuscript and
suggestions. We are thankful to Richard Kolodner for the yeast-based
RPA overexpression system, to Rodney Rothstein for the plasmid that
expresses histidine-tagged Rad52 protein, and to Sabrina Stratton for
excellent assistance.
 |
FOOTNOTES |
*
This work was supported by United States Public Health
Service Grant ES07061 from the NIEHS and by NIGMS Grant GM57814 from the National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular
Medicine/Inst. of Biotechnology, University of Texas Health Science
Center, 15355 Lambda Dr., San Antonio, TX 78245-3207. Tel.:
210-567-7216; Fax: 210-567-7277; E-mail: sung@uthscsa.edu.
Published, JBC Papers in Press, March 19, 2000, DOI 10.1074/jbc.M910244199
2
B. W. Song and P. Sung, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
ssDNA, single-stranded DNA;
dsDNA, double-stranded DNA;
DTT, dithiothreitol;
BSA, bovine serum albumin;
MOPS, 4-morpholinepropanesulfonic acid;
BIR, break-induced replication;
NTA, nitrilotriacetic acid;
RPA, replication
protein A.
 |
REFERENCES |
| 1.
|
Paques, F.,
and Haber, J. H.
(1999)
Microbiol. Mol. Biol. Rev.
63,
349-404
|
| 2.
|
Aboussekhra, A.,
Chanet, R.,
Adjiri, A.,
and Fabre, P.
(1992)
Mol. Cell. Biol.
12,
3224-3234
|
| 3.
|
Basile, G.,
Aker, M.,
and Mortimer, R. K.
(1992)
Mol. Cell. Biol.
12,
3235-3246
|
| 4.
|
Shinohara, A.,
Ogawa, H.,
and Ogawa, T.
(1992)
Cell
69,
457-470
|
| 5.
|
Ogawa, T., Yu, X.,
Shinohara, A.,
and Egelman, E. H.
(1993)
Science
259,
1896-1899
|
| 6.
|
Sung, P.,
and Robberson, D. L.
(1995)
Cell
82,
453-461
|
| 7.
|
Sung, P.,
and Stratton, S. A.
(1996)
J. Biol. Chem.
271,
27983-27986
|
| 8.
|
Sugiyama, T.,
Zaitseva, E. M.,
and Kowalczykowski, S. C.
(1997)
J. Biol. Chem.
272,
7940-7945
|
| 9.
|
Sung, P.
(1994)
Science
265,
1241-1243
|
| 10.
|
Baumann, P.,
Benson, F. E.,
and West, S. C.
(1996)
Cell
87,
757-766
|
| 11.
|
Gupta, R. C.,
Golub, E. I.,
Wold, M. S.,
and Radding, C. M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9843-9848
|
| 12.
|
New, J. H.,
Sugiyama, T.,
Zaitseva, E.,
and Kowalczykowski, S. C.
(1998)
Nature
391,
407-410
|
| 13.
|
Shinohara, A.,
and Ogawa, T.
(1998)
Nature
391,
404-407
|
| 14.
|
Sung, P.
(1997)
Genes Dev.
11,
1111-1112
|
| 15.
|
Sung, P.
(1997)
J. Biol. Chem.
272,
28194-28197
|
| 16.
|
Kanaar, R.,
and Hoeijmakers, J. H.
(1998)
Nature
391,
335-338
|
| 17.
|
Umezu, K. N.,
Chi, W.,
and Kolodner, R. D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3875-3879
|
| 18.
|
Harris, L. D.,
and Griffith, J. D.
(1989)
J. Mol. Biol.
206,
19-28
|
| 19.
|
Jiang, H.,
Giedroc, D.,
and Kodadek, T.
(1993)
J. Biol. Chem.
268,
7904-7911
|
| 20.
|
Yonesaki, T.,
and Minagawa, T.
(1989)
J. Biol. Chem.
264,
7814-7820
|
| 21.
|
Sweezy, M. A.,
and Morrical, S. C.
(1997)
J. Mol. Biol.
266,
927-938
|
|